london euretina
retina race

AMD: neovascular AMD reated by aflibercept (Eylea) proreactive protocol

Session Details

Session Title: AMD III

Session Date/Time: Sunday 20/09/2015 | 11:00-13:00

Paper Time: 12:44

Venue: Athena

First Author: : C.Gonzalez FRANCE

Co Author(s): :                  

Abstract Details

PURPOSE:To evaluate the functional, anatomical, vascular flow, effects of intravitreal Aflibercept injections (IVT) for subretinal neovascularization complicating AMD, done with Proreactive protocol, and the recurrences frequency at 1 year ½ follow-up

Setting:

Interventional, non comparative, retrospective case series

Methods:

60 eyes of 47 patients, 17 men, 30 women, with subretinal neovascularization complicating AMD. 52 eyes were switch cases, 8 naïve cases. Patients received intravitreous Aflibercept (Eylea) with Proreactive protocol: such as, firstly an inductive treatment ( 3 monthly IVT ), then series of 3 IVT (IVT done every 6 weeks ), every time in case of active neovascularization present. The score of all follow-up exams assessment determine neovascular activity and so if neovascularization is active or no. First exam, 2 months, and then 3 months’ interval follow-up exam included ETDRS visual acuity (VA), complete ophthalmic examination with ocular fundus, optical coherence tomography (spectral domain OCT), fluorescein (FA) and infracyanine (ICG) angiography (SLO Spectralis HRA-OCT).VA and OCT were done before each IVT. We want to evaluate the incidence of this protocol on the functional results and frequency of recurrences so on the number of IVT needed.

Results:

VA improved in 44% cases, more than 10 letters in 22% cases. Diffuse edema was 30% reduced in 88% , pigment epithelial detachment was flattened and less dense in all cases, by OCT. Angiographic leakage reduced about 70% in 68% cases, 30% in 96% cases. At ICG, vascular flow, vessel’s diameter were 2/3 time less in 71% cases, 1/3 in 97% cases. Most of patients had good functional, anatomical, vascular flow, results, with less IVT needed, with follow-up reliable and less frequent. Inductive treatment was sufficient in 49% cases, needed added series of IVT in 51% cases. Neovascular activity criteria and definition of active neovascularization are main points for follow-up and treatment indications. This protocol was compared, discussed.

Conclusions:

The results, with generally improved visual function, reduction of exudation on OCT, lack of fluorescein leakage, low neovascularization’s flow in ICG, less recurrences, suggest Proreactive Eylea protocol seems effective, less restrictive, lastly cheaper. This protocol appears attractive, its indication must be optimized.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy